RU2768746C2 - Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы - Google Patents

Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы Download PDF

Info

Publication number
RU2768746C2
RU2768746C2 RU2019121694A RU2019121694A RU2768746C2 RU 2768746 C2 RU2768746 C2 RU 2768746C2 RU 2019121694 A RU2019121694 A RU 2019121694A RU 2019121694 A RU2019121694 A RU 2019121694A RU 2768746 C2 RU2768746 C2 RU 2768746C2
Authority
RU
Russia
Prior art keywords
ethyl
tetrahydropyran
spiro
oxo
dihydro
Prior art date
Application number
RU2019121694A
Other languages
English (en)
Russian (ru)
Other versions
RU2019121694A (ru
RU2019121694A3 (cg-RX-API-DMAC7.html
Inventor
Сифу ЛЯН
Йенс ЛАРСЕН
Симон Фельдбек НИЛЬСЕН
Петер АНДЕРСЕН
Original Assignee
Юнион Терапьютикс А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнион Терапьютикс А/С filed Critical Юнион Терапьютикс А/С
Publication of RU2019121694A publication Critical patent/RU2019121694A/ru
Publication of RU2019121694A3 publication Critical patent/RU2019121694A3/ru
Application granted granted Critical
Publication of RU2768746C2 publication Critical patent/RU2768746C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2019121694A 2016-12-12 2017-12-12 Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы RU2768746C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16203335.1 2016-12-12
EP16203335 2016-12-12
PCT/EP2017/082424 WO2018108910A1 (en) 2016-12-12 2017-12-12 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

Publications (3)

Publication Number Publication Date
RU2019121694A RU2019121694A (ru) 2021-01-12
RU2019121694A3 RU2019121694A3 (cg-RX-API-DMAC7.html) 2021-01-21
RU2768746C2 true RU2768746C2 (ru) 2022-03-24

Family

ID=57542834

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019121694A RU2768746C2 (ru) 2016-12-12 2017-12-12 Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы

Country Status (7)

Country Link
US (2) US11065257B2 (cg-RX-API-DMAC7.html)
EP (1) EP3551632B1 (cg-RX-API-DMAC7.html)
JP (1) JP7008073B2 (cg-RX-API-DMAC7.html)
CN (1) CN110167944B (cg-RX-API-DMAC7.html)
ES (1) ES2981006T3 (cg-RX-API-DMAC7.html)
RU (1) RU2768746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018108910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018286964B2 (en) 2017-06-20 2022-04-14 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2019115776A1 (en) 2017-12-15 2019-06-20 Leo Pharma A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005071B1 (ru) * 2000-01-05 2004-10-28 Уорнер-Ламберт Компани ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ
WO2007040435A1 (en) * 2005-10-03 2007-04-12 Astrazeneca Ab Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease.
WO2008060597A2 (en) * 2006-11-15 2008-05-22 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423031B2 (en) 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
WO2007115232A2 (en) * 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
GB0704652D0 (en) 2007-03-09 2007-04-18 Syngenta Participations Ag Novel herbicides
WO2011003005A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
CN110088108B (zh) * 2016-12-12 2024-06-14 联合疗法公司 取代的吡唑并氮杂䓬-4-酮类及其作为磷酸二酯酶抑制剂的用途
ES2874632T3 (es) * 2016-12-12 2021-11-05 Union Therapeutics As Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005071B1 (ru) * 2000-01-05 2004-10-28 Уорнер-Ламберт Компани ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ
WO2007040435A1 (en) * 2005-10-03 2007-04-12 Astrazeneca Ab Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease.
WO2008060597A2 (en) * 2006-11-15 2008-05-22 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinase inhibitors

Also Published As

Publication number Publication date
CN110167944B (zh) 2024-08-23
US11065257B2 (en) 2021-07-20
WO2018108910A1 (en) 2018-06-21
RU2019121694A (ru) 2021-01-12
JP7008073B2 (ja) 2022-01-25
EP3551632B1 (en) 2024-06-12
US20220362259A1 (en) 2022-11-17
CN110167944A (zh) 2019-08-23
EP3551632C0 (en) 2024-06-12
JP2020511410A (ja) 2020-04-16
US20200323869A1 (en) 2020-10-15
EP3551632A1 (en) 2019-10-16
ES2981006T3 (es) 2024-10-04
RU2019121694A3 (cg-RX-API-DMAC7.html) 2021-01-21

Similar Documents

Publication Publication Date Title
JP7198820B2 (ja) 置換アゼチジンジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用
RU2583787C2 (ru) Гетероциклические соединения бензодиоксола или бензодиоксепина в качестве ингибиторов фосфодиэстераз
EP3724195B1 (en) Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
EP3724196B9 (en) Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
CN111108109A (zh) 取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途
CA2651454A1 (en) Imidazoazephinone compounds
RU2762279C2 (ru) Замещенные пиразолоазепин-4-оны и их применение в качестве ингибиторов фосфодиэстеразы
CN104011048B (zh) 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用
EP3551632B1 (en) Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
RU2764273C2 (ru) Замещенные пиразолоазепин-8-оны и их применение в качестве ингибиторов фосфодиэстеразы
RU2817698C2 (ru) Замещенные дигидротиенопиримидины и их применение в качестве ингибиторов фосфодиэстеразы
HK40041147A (en) Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
HK40039957A (en) Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
HK40039957B (en) Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
HK40041148A (en) Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
HK40041148B (en) Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant